|
Canada-641112-Insurance Azienda Directories
|
Azienda News:
- Tamar Oostrom
My areas of specialization are health economics and public economics My research focuses on the role of public policy and innovation in health care markets Recent projects have focused on the effect of representation in clinical trials and the relationship between religiosity and deaths of despair
- Tamar Oostrom | Department of Economics
My areas of specialization are health economics and public economics My research focuses on the role of public policy and innovation in health care markets Recent projects have focused on the effect of representation in clinical trials and the relationship between religiosity and deaths of despair
- Tamar Oostrom
Outpatient Wait Times and Quality of Care for Medicaid Patients (with Amy Finkelstein and Liran Einav), Health Affairs, 36(5), May 2017, pp 826-832
- Tamar Oostrom - Google Scholar
Tamar Oostrom Assistant Professor, The Ohio State University, Department of Economics Verified email at osu edu - Homepage Health economics Public economics
- Tamar Oostrom - IDEAS RePEc
Tamar Oostrom: current contact information and listing of economic research of this author provided by RePEc IDEAS
- Tamar Oostrom - Assistant Professor Of Economics at The Ohio State . . .
View Tamar Oostrom’s profile on LinkedIn, a professional community of 1 billion members
- Tamar Oostrom | NBER
Tamar Oostrom Faculty Research Fellow The Ohio State University Department of Economics
- Funding of Clinical Trials and Reported Drug Efficacy
This paper estimates the effect of financial sponsorship of clinical trials on reported drug efficacy, leveraging the insight that the exact same pairs of drugs are often compared in different trials conducted by parties with different financial interests
- Screening and Selection: The Case of Mammograms - American Economic . . .
We analyze selection into screening in the context of recommendations that breast cancer screening start at age 40 Combining medical claims with a clinical oncology model, we document that compliers with the recommendation are less likely to have cancer than younger women who select into screening or women who never screen
- Tamar Oostrom - UCLA Anderson Review
Ohio State University, Department of Economics, Assistant Professor
|
|